Michael Wagnes Sells 3,184 Shares of Allegion (NYSE:ALLE) Stock

Allegion PLC (NYSE:ALLE) CFO Michael Wagnes sold 3,184 shares of the firm’s stock in a transaction on Thursday, July 23rd. The stock was sold at an average price of $150.98, for a total value of $480,720.32. Following the transaction, the chief financial officer owned 31,299 shares in the company, valued at $4,725,523.02. This trade represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Allegion Stock Down 1.7%

ALLE stock opened at $158.43 on Thursday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.93 and a quick ratio of 1.23. Allegion PLC has a 1-year low of $125.00 and a 1-year high of $183.11. The firm has a fifty day moving average price of $136.68 and a two-hundred day moving average price of $146.66. The firm has a market cap of $13.47 billion, a price-to-earnings ratio of 20.79, a PEG ratio of 3.28 and a beta of 0.85.

Allegion (NYSE:ALLE) last issued its earnings results on Thursday, July 23rd. The scientific and technical instruments company reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.18. Allegion had a net margin of 15.36% and a return on equity of 35.41%. The company had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.12 billion. During the same period in the prior year, the company earned $2.04 earnings per share. The firm’s revenue was up 12.7% compared to the same quarter last year. Allegion has set its FY 2026 guidance at 8.850-9.000 EPS. Research analysts predict that Allegion PLC will post 8.92 EPS for the current year.

Allegion announced that its board has authorized a stock repurchase program on Tuesday, April 28th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the scientific and technical instruments company to buy up to 3.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

Allegion News Summary

Here are the key news stories impacting Allegion this week:

• Positive Sentiment: Allegion’s recent quarterly performance remains a key support for the stock. The company reported adjusted EPS of $2.40, exceeding estimates of $2.22, while revenue rose 12.7% year over year to $1.15 billion, above the $1.12 billion consensus. Management reaffirmed fiscal 2026 EPS guidance of $8.85–$9.00. Allegion earnings and stock information
• Positive Sentiment: The company’s $500 million share-repurchase authorization, potentially covering about 3.9% of outstanding shares, may provide ongoing support by signaling management’s confidence in the valuation. Institutional investors also hold approximately 92.2% of the stock, with several funds recently increasing their positions. Allegion insider and institutional ownership information
• Positive Sentiment: Momentum-focused coverage continues to highlight Allegion as a potentially attractive long-term stock, supported by its earnings growth, solid profitability and performance above its longer-term moving averages. Zacks Allegion momentum article
• Neutral Sentiment: Allegion gained during Tuesday’s session but lagged several industry peers, suggesting the stock lacked a company-specific catalyst strong enough to outperform the broader group. MarketWatch Allegion performance article
• Negative Sentiment: Several executives disclosed stock sales totaling about $1.60 million: CFO Michael Wagnes sold 3,184 shares, SVP Timothy Eckersley sold 6,417 shares and CAO Nickolas Musial sold 687 shares. The transactions were made under pre-arranged Rule 10b5-1 plans where disclosed, reducing the likelihood that they reflect new concerns, but insider selling can still weigh on sentiment.
• Negative Sentiment: Analyst sentiment remains cautious. Allegion carries a consensus “Hold” rating with an average price target of $164.75, while several firms have reduced targets; the stock’s elevated valuation relative to expected growth may limit near-term upside.

Hedge Funds Weigh In On Allegion

Several large investors have recently made changes to their positions in ALLE. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Allegion by 7.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,592 shares of the scientific and technical instruments company’s stock worth $1,251,000 after buying an additional 626 shares in the last quarter. NewEdge Advisors LLC boosted its stake in Allegion by 35.3% in the 1st quarter. NewEdge Advisors LLC now owns 3,272 shares of the scientific and technical instruments company’s stock worth $427,000 after purchasing an additional 854 shares during the period. Jones Financial Companies Lllp grew its position in Allegion by 44.2% during the 1st quarter. Jones Financial Companies Lllp now owns 1,629 shares of the scientific and technical instruments company’s stock worth $213,000 after purchasing an additional 499 shares in the last quarter. Empowered Funds LLC grew its position in Allegion by 13.0% during the 1st quarter. Empowered Funds LLC now owns 5,673 shares of the scientific and technical instruments company’s stock worth $740,000 after purchasing an additional 651 shares in the last quarter. Finally, Focus Partners Wealth raised its stake in Allegion by 204.5% during the 1st quarter. Focus Partners Wealth now owns 7,186 shares of the scientific and technical instruments company’s stock valued at $937,000 after purchasing an additional 4,826 shares during the period. Institutional investors own 92.21% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on ALLE shares. Bank of America lowered their target price on Allegion from $185.00 to $157.00 and set a “neutral” rating for the company in a report on Monday, April 20th. Robert W. Baird set a $170.00 price target on Allegion in a report on Friday, July 24th. JPMorgan Chase & Co. boosted their price objective on Allegion from $150.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, July 24th. Barclays dropped their target price on Allegion from $165.00 to $161.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 29th. Finally, Wells Fargo & Company cut their target price on Allegion from $175.00 to $155.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 1st. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $164.75.

Allegion Company Profile

Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is head­quartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.

The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.